Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy

Synucleinopathies are diverse diseases with motor and cognitive dysfunction due to progressive neuronal loss or demyelination, due to oligodendrocyte loss in the brain. While the etiology of neurodegenerative disorders (NDDs) is likely multifactorial, mitochondrial injury is one of the most vital fa...

Full description

Bibliographic Details
Main Authors:	An Cheng, Wenbin Jia, Ichiro Kawahata, Kohji Fukunaga
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Biomedicines
Subjects:	α-synuclein fatty acid-binding proteins neurodegenerative disorders mitochondria
Online Access:	https://www.mdpi.com/2227-9059/9/5/560

Similar Items

Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury under Oxidative Stress
by: Yifei Wang, et al.
Published: (2021-01-01)

Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson’s Disease—Potential Biomarkers and Therapeutic Targets
by: Ichiro Kawahata, et al.
Published: (2023-12-01)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)

Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies
by: Hideki Oizumi, et al.
Published: (2021-03-01)

A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
by: An Cheng, et al.
Published: (2021-10-01)

Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons
by: Qingyun Guo, et al.
Published: (2023-02-01)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
by: Jacob S. Deyell, et al.
Published: (2023-01-01)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01)

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets
by: Qingyun Guo, et al.
Published: (2022-08-01)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
by: Matthias Schmitz, et al.
Published: (2023-03-01)

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
by: Ichiro Kawahata, et al.
Published: (2020-05-01)

The Synucleins and the Astrocyte
by: Abigail J. Myers, et al.
Published: (2023-01-01)

Cytotoxicity and Mitochondrial Dysregulation Caused by α-Synuclein in <i>Dictyostelium discoideum</i>
by: Sanjanie Fernando, et al.
Published: (2020-10-01)

The Non-Fibrillating N-Terminal of α-Synuclein Binds and Co-Fibrillates with Heparin
by: Line K. Skaanning, et al.
Published: (2020-08-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
by: Davide Chiasserini, et al.
Published: (2017-07-01)

Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons
by: Ichiro Kawahata, et al.
Published: (2021-01-01)

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
by: Maria Fouka, et al.
Published: (2020-09-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
by: Zachary A. Sorrentino, et al.
Published: (2017-05-01)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01)

FABP2 is Involved in Intestinal α-Synuclein Pathologies
by: Tomoki Sekimori, et al.
Published: (2024-02-01)

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease
by: Pablo Gracia, et al.
Published: (2020-10-01)

Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
by: Tritia R. Yamasaki, et al.
Published: (2020-05-01)

Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice
by: Haoyang Wang, et al.
Published: (2023-05-01)

Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique
by: Ichiro Kawahata, et al.
Published: (2023-08-01)

Biochemical Fractionation of Human α-Synuclein in a <i>Drosophila</i> Model of Synucleinopathies
by: Khondamir Imomnazarov, et al.
Published: (2024-03-01)

Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014-12-01)

How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
by: Senthil T. Kumar, et al.
Published: (2020-12-01)

Crucial Role of FABP3 in αSyn-Induced Reduction of Septal GABAergic Neurons and Cognitive Decline in Mice
by: Kazuya Matsuo, et al.
Published: (2021-01-01)

O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
by: Willayat Y. Wani, et al.
Published: (2017-07-01)

Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
by: Jae-Hyeon Park, et al.
Published: (2020-01-01)

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
by: Darren M. O’Hara, et al.
Published: (2020-06-01)

Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
by: Cathryn L. Ugalde, et al.
Published: (2020-01-01)

Apoptosis, Induced by Human α-Synuclein in Yeast, Can Occur Independent of Functional Mitochondria
by: Damilare D. Akintade, et al.
Published: (2020-09-01)

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity
by: Kelley C. O’Donnell, et al.
Published: (2014-05-01)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
by: Gabriel Gustafsson, et al.
Published: (2017-12-01)

ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
by: Fei Gao, et al.
Published: (2022-09-01)